Zurich Cantonal Bank
GBT

Zurich Cantonal Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Zurich Cantonal Bank’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,291
Closed -$701K – 2965
2022
Q3 		$701K Sell
10,291
-34,145
-77% -$1.88M ﹤0.01% 989
2022
Q2 		$1.42M Sell
44,436
-147
-0.3% -$4.3K 0.01% 752
2022
Q1 		$1.54M Sell
44,583
-1,288
-3% -$38.5K 0.01% 786
2021
Q4 		$1.34M Buy
45,871
+7,099
+18% +$220K 0.01% 880
2021
Q3 		$988K Buy
38,772
+10,741
+38% +$316K 0.01% 934
2021
Q2 		$982K Sell
28,031
-1,178
-4% -$46K 0.01% 900
2021
Q1 		$1.19M Sell
29,209
-682
-2% -$31.3K 0.01% 832
2020
Q4 		$1.29M Buy
29,891
+23,205
+347% +$1.14M 0.01% 855
2020
Q3 		$369K Hold
6,686
– – ﹤0.01% 1235
2020
Q2 		$422K Buy
6,686
+1,692
+34% +$116K ﹤0.01% 1102
2020
Q1 		$255K Buy
4,994
+1,180
+31% +$79K ﹤0.01% 1110
2019
Q4 		$303K Hold
3,814
– – ﹤0.01% 1121
2019
Q3 		$185K Buy
3,814
+549
+17% +$28.6K ﹤0.01% 1278
2019
Q2 		$172K Buy
3,265
+482
+17% +$27.7K ﹤0.01% 1309
2019
Q1 		$147K Sell
2,783
-324
-10% -$15.9K ﹤0.01% 1338
2018
Q4 		$128K Hold
3,107
– – ﹤0.01% 1453
2018
Q3 		$118K Buy
3,107
+521
+20% +$23.1K ﹤0.01% 1624
2018
Q2 		$117K Sell
2,586
-835
-24% -$38K ﹤0.01% 1562
2018
Q1 		$165K Buy
3,421
+516
+18% +$28.8K ﹤0.01% 1306
2017
Q4 		$114K Buy
2,905
+550
+23% +$20.5K ﹤0.01% 1496
2017
Q3 		$73K Hold
2,355
– – ﹤0.01% 1571
2017
Q2 		$64K Buy
2,355
+336
+17% +$10K ﹤0.01% 1619
2017
Q1 		$74K Buy
+2,019
New +$50.9K ﹤0.01% 1549

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zurich Cantonal Bank's GBT Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 10,291 shares — an estimated $701K sold.

Zurich Cantonal Bank first reported a position in GBT in Q1 2017 and held it in 23 quarters. The position peaked at $1.54M in Q1 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 10,291 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $701K.
  • Zurich Cantonal Bank first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 23 quarters.
  • Zurich Cantonal Bank's Global Blood Therapeutics, Inc. position peaked at $1.54M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.